OVERVIEW
The market for next-generation sequencing (NGS) is expected to hit USD 24.42 billion by 2025, rising over the forecast period at a CAGR of 20.93 per cent. Growth in this segment is guided primarily by advancements in and decreasing NGS product costs and improving regulatory and reimbursement scenario for NGS-based diagnostic testing.
TABLE OF CONTENT
1 Global Next-generation Sequencing (NGS) Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Next-generation Sequencing (NGS) Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Next-generation Sequencing (NGS) Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Next-generation Sequencing (NGS) Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Next-generation Sequencing (NGS) Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Next-generation Sequencing (NGS) Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Next-generation Sequencing (NGS) Market – By Product & Service (Market Size – &
million/billion)
8.1 Presequencing Products & Services
8.2 NGS consumables
8.3 Services for NGS Platforms
8.4 Sequencing Services
8.5 Bioinformatics
8.6 NGS Platforms
9 Global Next-generation Sequencing (NGS) Market – By Technology
9.1 Sequencing by Synthesis
9.2 Ion Semiconductor Sequencing
9.3 Single-molecule Real-time Sequencing
9.4 Nanopore Sequencing
9.5 Other
10 Global Next-generation Sequencing (NGS) Market – By Application
10.1 Diagnostics
10.2 Drug Discovery
10.3 Agriculture & Animal Research
10.4 Other
11 Global Next-generation Sequencing (NGS) Market – By End-User
11.1 Academic Institutes & Research Centers
11.2 Hospitals & Clinics
11.3 Pharmaceutical & Biotechnology Companies
11.4 Other
12 Global Next-generation Sequencing (NGS) Market – By Geography (Market Size – &
million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Next-generation Sequencing (NGS) Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Next-generation Sequencing (NGS) Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Illumina, Inc.
14.3 Thermo Fisher Scientific, Inc.
14.4 BGI Group
14.5 Perkinelmer
14.6 Eurofins Scientific
14.7 Psomagen, Inc. (Formerly Known as Macrogen)
14.8 Agilent Technologies, Inc.
14.9 Genewiz (A Part of Brooks Automation)
14.10 Qiagen N.V.
14.11 F. Hoffmann-La Roche AG
14.12 Company 11 & more
15 Global Next-generation Sequencing (NGS) Market – Appendix
15.1 Sources
15.2 Abbreviations